Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder

Fertility and Sterility

Volumn 88, Issue 5, 2007, Pages 1442-1445

  Frankfurter, David ^a   Dayal, Molina ^a   Dubey, Anil ^a   Peak, Douglas ^a   Gindoff, Paul ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; GONADORELIN ANTAGONIST; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; NIDATION; OVARY FOLLICLE; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; PREGNANCY;

EID: 35648949392     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.022     Document Type: Article

References (22)

1. Gardner D.K., and Lane M. Culture of viable human blastocysts in defined sequential serum-free media. Hum Reprod 13 Suppl 3 (1998) 148-159 [discussion: 160]
2. Munne S., Alikani M., Tomkin G., Grifo J., and Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 64 (1995) 382-391
3. Daya S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril 77 (2002) 711-714
4. Reynolds M.A., Schieve L.A., Jeng G., and Peterson H.B. Does insurance coverage decrease the risk for multiple births associated with assisted reproductive technology?. Fertil Steril 80 (2003) 16-23
5. Surrey E.S., and Schoolcraft W.B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73 (2000) 667-676
6. Gindoff P.R., and Jewelewicz R. Reproductive potential in the older woman. Fertil Steril 46 (1986) 989-1001
7. Speroff L., Glass R.L., and Kase N.G. Clinical gynecologic endocrinology and infertility. 6th ed. (1999), Lippincott Williams and Wilkins, Baltimore, MD
8. Karande V., Morris R., Rinehart J., Miller C., Rao R., and Gleicher N. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 67 (1997) 900-903
9. Land J.A., Yarmolinskaya M.I., Dumoulin J.C., and Evers J.L. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 65 (1996) 961-965
10. McNatty K.P., Smith D.M., Makris A., Osathanondh R., and Ryan K.J. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49 (1979) 851-860
11. Erickson G.F., Magoffin D.A., Dyer C.A., and Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 6 (1985) 371-399
12. Biljan M.M., Mahutte N.G., Dean N., Hemmings R., Bissonnette F., and Tan S.L. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70 (1998) 1063-1069
13. McKenna K.M., Foster P., McBain J., Martin M., and Johnston W.I. Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results. Aust NZ J Obstet Gynaecol 29 (1989) 428-432
14. Horvath P.M., Styler M., Hammond J.M., Shelden R.M., and Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 49 (1988) 159-162
15. Loumaye E., Vankrieken L., Depreester S., Psalti I., de Cooman S., and Thomas K. Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril 51 (1989) 105-111
16. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320
17. Copperman A.B. Antagonists in poor-responder patients. Fertil Steril 80 Suppl 1 (2003) S16-S24
18. Martin L., Marek D., Doody K., Nackley A., and Doody K. Daily low dose recombinant hCG and recombinant FSH: a novel stimulation protocol for IVF. Fertil Steril 78 Suppl 1 (2002) S19
19. Frankfurter D., Trimarchi J.B., Silva C.P., and Keefe D.L. Middle to lower uterine segment embryo transfer improves implantation and pregnancy rates compared with fundal embryo transfer. Fertil Steril 81 (2004) 1273-1277
20. Shikone T., Yamoto M., Kokawa K., Yamashita K., Nishimori K., and Nakano R. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 81 (1996) 2376-2380
21. Brzyski R.G., Muasher S.J., Droesch K., Simonetti S., Jones G.S., and Rosenwaks Z. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 50 (1988) 917-921
22. Shapiro D.B. GnRH antagonists in normal-responder patients. Fertil Steril 80 Suppl 1 (2003) S8-S15 [discussion: S14-32]